Emil Pot has more than 20 years of experience in technology transfer and biotech start-up companies. He is the co-founder of ActoGenix, IP expert at NLO, Business Devevelopment at Oncode Institute and co-founder of Allero Therapeutics.

Emil has obtained a LL.M. from University of Groningen, studied life sciences while at VIB and is a qualified European Patent Attorney.


  • Business development
  • IP
  • Leg
This website uses cookies

Some cookies are necessary for the proper functioning of our website and therefore can’t be refused if you wish to visit the site. Other cookies help us analyze data, these cookies can be refused.

More information about cookies